<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39336530</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Imaging and Biomarkers: The Assesment of Pulmonary Embolism Risk and Early Mortality.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1489</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina60091489</ELocationID><Abstract><AbstractText><i>Background and Objectives</i>: Pulmonary embolism (PE) incidence has been increasing in the last 10 years. Computed thoracic pulmonary angiography (CTPA) had a major role in PE diagnosis and prognosis. The main purpose of this study was as follows: the prognostic value of a CTPA parameter, pulmonary artery obstruction index (PAOI), in PE risk assessment and the predictive accuracy of biomarkers, D-dimer and cardiac Troponin T (c-TnT), in 7-day mortality. A second objective of the research was to investigate the relationship between imaging by PAOI and these biomarkers in different etiologies of PE. <i>Materials and Methods</i>: This study comprised 109 patients with PE, hospitalized and treated between February 2021 and August 2022. They had different etiologies of PE: deep vein thrombosis (DVT); persistent atrial fibrillation (AF); chronic obstructive pulmonary disease (COPD) exacerbation; COVID-19; and cancers. The investigations were as follows: clinical examination; D-dimer testing, as a mandatory method for PE suspicion (values ≥500 µg/L were highly suggestive for PE); c-TnT, as a marker of myocardial injury (values ≥14 ng/L were abnormal); CTPA, with right ventricle dysfunction (RVD) signs and PAOI. Treatments were according to PE risk: systemic thrombolysis in high-risk PE; low weight molecular heparins (LWMH) in high-risk PE, after systemic thrombolysis or from the beginning, when systemic thrombolysis was contraindicated; and direct oral anticoagulants (DOAC) in low- and intermediate-risk PE. <i>Results</i>: PAOI had a high predictive accuracy for high-risk PE (area under curve, AUC = 0.993). D-dimer and cTnT had a statistically significant relationship with 7-day mortality for the entire sample, <i>p</i> &lt; 0.001, and for AF, <i>p</i> = 0.0036; COVID-19, <i>p</i> = 0.003; and cancer patients, <i>p</i> = 0.005. PAOI had statistical significance for 7-day mortality only in COVID-19, <i>p</i> = 0.045, and cancer patients, <i>p</i> = 0.038. The relationship PAOI-D-dimer and PAOI-c-TnT had very strong statistical correlation for the entire sample and for DVT, AF, COPD, and COVID-19 subgroups (Rho = 0.815-0.982). <i>Conclusions</i>: PAOI was an important tool for PE risk assessment. D-dimer and c-TnT were valuable predictors for 7-day mortality in PE. PAOI (imaging parameter for PE extent) and D-dimer (biomarker for PE severity) as well as PAOI and c-TnT (biomarker for myocardial injury) were strongly correlated for the entire PE sample and for DVT, AF, COPD, and COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naum</LastName><ForeName>Alexandru Gratian</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>2nd Morphofunctional Sciences Department, Biophysics and Medical Physics, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Neolife" Medical Center, 52 Carol I Avenue, 700503 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jari</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>2nd Surgical Department, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St. Spiridon Emergency Hospital, Radiology and Medical Imaging Clinique, 1st Independentei Avenue, 700111 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisii</LastName><ForeName>Liliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>2nd Surgical Department, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St. Spiridon Emergency Hospital, Radiology and Medical Imaging Clinique, 1st Independentei Avenue, 700111 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ursu</LastName><ForeName>Andra Mara</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>St. Spiridon Emergency Hospital, Radiology and Medical Imaging Clinique, 1st Independentei Avenue, 700111 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisii</LastName><ForeName>Paloma</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>1st Medical Department "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Promedicanon "Cardiology Office", 15 Prisacii Valley, 707410 Valea Lupului, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020107">Troponin T</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="Y">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020107" MajorTopicYN="Y">Troponin T</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="N">Computed Tomography Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">cardiac troponin T</Keyword><Keyword MajorTopicYN="N">pulmonary artery obstruction index</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39336530</ArticleId><ArticleId IdType="pmc">PMC11433879</ArticleId><ArticleId IdType="doi">10.3390/medicina60091489</ArticleId><ArticleId IdType="pii">medicina60091489</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pollack C.V., Schreiber D., Goldhaber S.Z., Slattery D., Fanikos J., O’Neil B.J., Thompson J.R., Hiestand B., Briese B.A., Pendleton R.C., et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: Initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry) J. Am. Coll. Cardiol. 2011;57:700–706. doi: 10.1016/j.jacc.2010.05.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.05.071</ArticleId><ArticleId IdType="pubmed">21292129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao C.W., Aday A.W., Almarzooq Z.I., Alonso A., Beaton A.Z., Bittencourt M.S., Boehme A.K., Buxton A.E., Carson A.P., Commodore-Mensah Y., et al.  Heart Disease and Stroke Statistics-2022 Update: A Report from the American Heart Association. Circulation. 2022;145:e153–e639. doi: 10.1161/CIR.0000000000001052. Erratum in Circulation
2022, 146, e141. https://doi.org/10.1161/CIR.0000000000001074 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001052</ArticleId><ArticleId IdType="pubmed">35078371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Cate V., Prochaska J.H., Schulz A., Nagler M., Robles A.P., Jurk K., Koeck T., Rapp S., Düber C., Münzel T., et al. Clinical profile and outcome of isolated pulmonary embolism: A systematic revie and meta-analysis. E Clin. Med. 2023;59:101973. doi: 10.1016/j.eclinm.2023.101973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101973</ArticleId><ArticleId IdType="pmc">PMC10154961</ArticleId><ArticleId IdType="pubmed">37152363</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moerloose P., Reber G., Perrier A., Perneger T., Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br. J. Haematol. 2000;110:125–129. doi: 10.1046/j.1365-2141.2000.02039.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2000.02039.x</ArticleId><ArticleId IdType="pubmed">10930988</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni E., Marcucci R., Ciuti G., Cenci C., Poli D., Mannini L., Liotta A.A., Miniati M., Abbate R., Prisco D. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: A survey of 443 cases of venous thromboembolism. Semin. Thromb. Hemost. 2012;38:230–234. doi: 10.1055/s-0032-1301420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1301420</ArticleId><ArticleId IdType="pubmed">22422337</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Tuo Y., Shi X., Duo J., Liu X., Zhang F., Feng X. Prevalence, risk factors, and clinical characteristics of pulmonary embolism in patients with acute exacerbation of COPD in Plateau regions: A prospective cohort study. BMC. Pulm. Med. 2024;24:102. doi: 10.1186/s12890-024-02915-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-024-02915-z</ArticleId><ArticleId IdType="pmc">PMC10900782</ArticleId><ArticleId IdType="pubmed">38413975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Cate V., Eggebrecht L., Schulz A., Panova-Noeva M., Lenz M., Koeck T., Rapp S., Arnold N., Lackner K.J., Konstantinides S., et al. Isolated Pulmonary Embolism Is Associated with a High Risk of Arterial Thrombotic Disease: Results from the VTEval Study. Chest. 2020;158:341–349. doi: 10.1016/j.chest.2020.01.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.01.055</ArticleId><ArticleId IdType="pubmed">32217063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Cate V., Prochaska J.H., Schulz A., Koeck T., Pallares Robles A., Lenz M., Eggebrecht L., Rapp S., Panova-Noeva M., Ghofrani H.A., et al. Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism. Blood. 2021;137:2681–2693. doi: 10.1182/blood.2019004571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2019004571</ArticleId><ArticleId IdType="pmc">PMC9635523</ArticleId><ArticleId IdType="pubmed">33529319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A., Vecchié A., Dagna L., Martinod K., Dixon D.L., Van Tassell B.W., Dentali F., Montecucco F., Massberg S., Levi M., et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 2021;21:319–329. doi: 10.1038/s41577-021-00536-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Ismail M.Y., Diamond A., Kapoor S., Arafah Y., Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb. Res. 2020;194:101–115. doi: 10.1016/j.thromres.2020.06.029. Erratum in Thromb. Res.
2021, 204, 146. https://doi.org/10.1016/j.thromres.2020.11.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.029</ArticleId><ArticleId IdType="pmc">PMC7305763</ArticleId><ArticleId IdType="pubmed">32788101</ArticleId></ArticleIdList></Reference><Reference><Citation>De Godoy J.M.P., Dizero A.G., Lopes M.V.C.A. Prevalence of Pulmonary Embolism in COVID-19 at Quaternary Hospital Running Head: Pulmonary Embolism in COVID-19. Med. Arch. 2024;78:146–148. doi: 10.5455/medarh.2024.78.146-148.</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/medarh.2024.78.146-148</ArticleId><ArticleId IdType="pmc">PMC10983093</ArticleId><ArticleId IdType="pubmed">38566866</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S., Hron G., Bialonczyk C. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch. Intern. Med. 2008;168:1678–1683. doi: 10.1001/archinte.168.15.1678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.168.15.1678</ArticleId><ArticleId IdType="pubmed">18695082</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg I., Elgendy I.Y., Dicks A.B., Marchena P.J., Malý R., Francisco I., Pedrajas J.M., Font C., Hernández-Blasco L., Monreal M., et al. Comparison of Presentation, Treatment, and Outcomes of Venous Thromboembolism in Long-Term Immobile Patients Based on Age. J. Gen. Intern. Med. 2023;38:1877–1886. doi: 10.1007/s11606-023-08058-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-023-08058-x</ArticleId><ArticleId IdType="pmc">PMC10271988</ArticleId><ArticleId IdType="pubmed">36750505</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh T., Lavikainen L.I., Halme A.L.E., Aaltonen R., Agarwal A., Blanker M.H., Bolsunovskyi K., Cartwright R., García-Perdomo H., Gutschon R., et al. Timing of symptomatic venous thromboembolism after surgery: Meta-analysis. Br. J. Surg. 2023;110:553–561. doi: 10.1093/bjs/znad035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjs/znad035</ArticleId><ArticleId IdType="pmc">PMC10364527</ArticleId><ArticleId IdType="pubmed">36912116</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715–722. doi: 10.1001/jama.293.6.715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.293.6.715</ArticleId><ArticleId IdType="pubmed">15701913</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier M., Righini M., Djurabi R.K., Huisman M.V., Perrier A., Wells P.S., Rodger M., Wuillemin W.A., Le Gal G. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb. Haemost. 2009;101:886–892. doi: 10.1160/TH-08-10-0689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH-08-10-0689</ArticleId><ArticleId IdType="pubmed">19404542</ArticleId></ArticleIdList></Reference><Reference><Citation>Righini M., Le Gal G., De Lucia S., Roy P.M., Meyer G., Aujesky D., Bounameaux H., Perrier A. Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb. Haemost. 2006;95:715–719.</Citation><ArticleIdList><ArticleId IdType="pubmed">16601844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabloz P., Reber G., Boehlen F., Hohlfeld P., de Moerloose P. TAFI antigen and D-dimer levels during normal pregnancy and at delivery. Br. J. Haematol. 2001;115:150–152. doi: 10.1046/j.1365-2141.2001.03082.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2001.03082.x</ArticleId><ArticleId IdType="pubmed">11722426</ArticleId></ArticleIdList></Reference><Reference><Citation>Falster C., Hellfritzsch M., Gaist T.A., Brabrand M., Bhatnagar R., Nybo M., Andersen N.H., Egholm G. Comparison of international guideline recommendations for the diagnosis of pulmonary embolism. Lancet Haematol. 2023;10:e922–e935. doi: 10.1016/S2352-3026(23)00181-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(23)00181-3</ArticleId><ArticleId IdType="pubmed">37804848</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B., Muriel A., Rodríguez C., González S., Briceño W., Mehdipoor G., Piazza G., Ballaz A., Lippi G., Yusen R.D., et al. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients with Acute Pulmonary Embolism. JAMA Cardiol. 2024;9:64–70. doi: 10.1001/jamacardio.2023.4356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2023.4356</ArticleId><ArticleId IdType="pmc">PMC10666041</ArticleId><ArticleId IdType="pubmed">37991780</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonne-Holm E., Winther-Jensen M., Bang L.E., Køber L., Fosbøl E., Carlsen J., Kjaergaard J. Troponin dependent 30-day mortality in patients with acute pulmonary embolism. J. Thromb. Thrombolysis. 2023;56:485–494. doi: 10.1007/s11239-023-02864-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-023-02864-0</ArticleId><ArticleId IdType="pmc">PMC10439039</ArticleId><ArticleId IdType="pubmed">37486553</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D.K., Thilo C., Schoepf U.J., Barraza J.M., Jr., Nance J.W., Jr., Bastarrika G., Abro J.A., Ravenel J.G., Costello P., Goldhaber S.Z. CT signs of right ventricular dysfunction: Prognostic role in acute pulmonary embolism. JACC Cardiovasc. Imaging. 2011;4:841–849. doi: 10.1016/j.jcmg.2011.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2011.04.013</ArticleId><ArticleId IdType="pubmed">21835376</ArticleId></ArticleIdList></Reference><Reference><Citation>Qanadli S.D., El Hajjam M., Vieillard-Baron A., Joseph T., Mesurolle B., Oliva V.L., Barré O., Bruckert F., Dubourg O., Lacombe P. New CT index to quantify arterial obstruction in pulmonary embolism: Comparison with angiographic index and echocardiography. Am. J. Roentgenol. 2001;176:1415–1420. doi: 10.2214/ajr.176.6.1761415.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/ajr.176.6.1761415</ArticleId><ArticleId IdType="pubmed">11373204</ArticleId></ArticleIdList></Reference><Reference><Citation>Barco S., Mahmoudpour S.H., Planquette B., Sanchez O., Konstantinides S.V., Meyer G. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: A systematic review and meta-analysis. Eur. Heart J. 2019;40:902–910. doi: 10.1093/eurheartj/ehy873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy873</ArticleId><ArticleId IdType="pmc">PMC6416533</ArticleId><ArticleId IdType="pubmed">30590531</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer G., Vicaut E., Danays T., Agnelli G., Becattini C., Beyer-Westendorf J., Bluhmki E., Bouvaist H., Brenner B., Couturaud F., et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N. Engl. J. Med. 2014;370:1402–1411. doi: 10.1056/NEJMoa1302097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1302097</ArticleId><ArticleId IdType="pubmed">24716681</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G. Advanced Management of Intermediate- and High-Risk Pulmonary Embolism: JACC Focus Seminar. J. Am. Coll. Cardiol. 2020;76:2117–2127. doi: 10.1016/j.jacc.2020.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.05.028</ArticleId><ArticleId IdType="pubmed">33121720</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhalfan F., Bukhari S., Rosenzveig A., Moudgal R., Khan S.Z., Ghoweba M., Chaudhury P., Cameron S.J., Tefera L. The Obesity Mortality Paradox in Patients with Pulmonary Embolism: Insights from a Tertiary Care Center. J. Clin. Med. 2024;13:2375. doi: 10.3390/jcm13082375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13082375</ArticleId><ArticleId IdType="pmc">PMC11051153</ArticleId><ArticleId IdType="pubmed">38673648</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamami O., Tamami F., Gotur D.B. Clinical impact of morbid obesity on pulmonary embolism hospitalizations. Chest. 2023;164:A5949. doi: 10.1016/j.chest.2023.07.3834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2023.07.3834</ArticleId></ArticleIdList></Reference><Reference><Citation>Khasin M., Gur I., Evgrafov E.V., Toledano K., Zalts R. Clinical presentations of acute pulmonary embolism: A retrospective cohort study. Medicine. 2023;102:e34224. doi: 10.1097/MD.0000000000034224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000034224</ArticleId><ArticleId IdType="pmc">PMC10344497</ArticleId><ArticleId IdType="pubmed">37443506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Fan G., Zhang X., Xi L., Chen Y., Li A., Zhai Z. Prevalence of long-term right ventricular dysfunction after acute pulmonary embolism: A systematic review and meta-analysis. Lancet EClinicalMedicine. 2023;62:102153. doi: 10.1016/j.eclinm.2023.102153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102153</ArticleId><ArticleId IdType="pmc">PMC10448274</ArticleId><ArticleId IdType="pubmed">37638233</ArticleId></ArticleIdList></Reference><Reference><Citation>Quezada A., Jiménez D., Bikdeli B., Moores L., Porres-Aguilar M., Aramberri M., Lima J., Ballaz A., Yusen R.D., Monreal M., et al. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism. Int. J. Cardiol. 2020;302:157–163. doi: 10.1016/j.ijcard.2019.11.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2019.11.102</ArticleId><ArticleId IdType="pubmed">31761399</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein P.D., Matta F., Hughes M.J. Hospitalizations for High-Risk Pulmonary Embolism. Am. J. Med. 2021;134:621–625. doi: 10.1016/j.amjmed.2020.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2020.10.029</ArticleId><ArticleId IdType="pubmed">33245921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballas C., Lakkas L., Kardakari O., Konstantinidis A., Exarchos K., Tsiara S., Kostikas K., Naka K.Κ., Michalis L.K., Katsouras C.S. What is the real incidence of right ventricular affection in patients with acute pulmonary embolism? Acta Cardiol. 2023;78:1089–1098. doi: 10.1080/00015385.2023.2246197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00015385.2023.2246197</ArticleId><ArticleId IdType="pubmed">37581357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Tian X., Liu X.W., Liu Y.Z., Gao B.L., Li C.Y. Markers of right ventricular dysfunction predict 30-day adverse prognosis of pulmonary embolism on pulmonary computed tomographic angiography. Medicine. 2023;102:e34304. doi: 10.1097/MD.0000000000034304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000034304</ArticleId><ArticleId IdType="pmc">PMC10344539</ArticleId><ArticleId IdType="pubmed">37443496</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen E.T., Hague C., Manos D., Memauri B., Souza C., Taylor J., Dennie C. Canadian Society of Thoracic Radiology/Canadian Association of Radiologists Best Practice Guidance for Investigation of Acute Pulmonary Embolism, Part 1: Acquisition and Safety Considerations. Can. Assoc. Radiol. J. 2022;73:203–213. doi: 10.1177/08465371211000737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08465371211000737</ArticleId><ArticleId IdType="pubmed">33781098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanima W., Abdelnoar M., Holmen L.O., Nielssen B.E., Ross S., Sandset P.M. D-dimer level is associated with the extent of PE. Throm. Res. 2007;120:281–288. doi: 10.1016/j.thromres.2006.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2006.08.006</ArticleId><ArticleId IdType="pubmed">17030057</ArticleId></ArticleIdList></Reference><Reference><Citation>Çil E., Çoraplı M., Karadeniz G., Çoraplı G., Başbuğ Baltalı T. The relationship between pulmonary artery obstruction index and troponin in thorax computed tomography in pulmonary embolism. J. Health Sci. Med./JHSM. 2022;5:1361–1365. doi: 10.32322/jhsm.1127534.</Citation><ArticleIdList><ArticleId IdType="doi">10.32322/jhsm.1127534</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel N.A., Roddick A., Glampson B. Prognostic significance of troponin in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study) Cardio-Oncology. 2024;10:41. doi: 10.1186/s40959-024-00238-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40959-024-00238-w</ArticleId><ArticleId IdType="pmc">PMC11225146</ArticleId><ArticleId IdType="pubmed">38970129</ArticleId></ArticleIdList></Reference><Reference><Citation>Inönü H., Acu B., Pazarlı A.C., Doruk S., Erkorkmaz Ü., Altunkaş A. The value of the computed tomographic obstruction index in the identification of massive pulmonary thromboembolism. Diagn. Interv. Radiol. 2012;18:255–260. doi: 10.4261/1305-3825.DIR.4597-11.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.4261/1305-3825.DIR.4597-11.4</ArticleId><ArticleId IdType="pubmed">22249888</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiménez D., de Miguel-Díez J., Guijarro R., Trujillo-Santos J., Otero R., Barba R., Muriel A., Meyer G., Yusen R.D., Monreal M., et al. Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis from the RIETE Registry. J. Am. Coll. Cardiol. 2016;67:162–170. doi: 10.1016/j.jacc.2015.10.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.10.060</ArticleId><ArticleId IdType="pubmed">26791063</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhoundi N., Faghihi Langroudi T., Rezazadeh E., Rajebi H., Komijani Bozchelouei J., Sedghian S., Sarfaraz T., Heydari N. Role of Clinical and Echocardiographic Findings in Patients with Acute Pulmonary Embolism: Prediction of Adverse Outcomes and Mortality in 180 Days. Tanaffos. 2021;20:99–108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8710213</ArticleId><ArticleId IdType="pubmed">34976080</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunton N., McBane R., Casanegra A.I., Houghton D.E., Balanescu D.V., Ahmad S., Caples S., Motiei A., Henkin S. Risk Stratification and Management of Intermediate-Risk Acute Pulmonary Embolism. J. Clin. Med. 2024;13:257. doi: 10.3390/jcm13010257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13010257</ArticleId><ArticleId IdType="pmc">PMC10779572</ArticleId><ArticleId IdType="pubmed">38202264</ArticleId></ArticleIdList></Reference><Reference><Citation>Karolak B., Ciurzyński M., Skowrońska M., Kurnicka K., Pływaczewska M., Furdyna A., Perzanowska-Brzeszkiewicz K., Lichodziejewska B., Pacho S., Machowski M., et al. Plasma Troponins Identify Patients with Very Low-Risk Acute Pulmonary Embolism. J. Clin. Med. 2023;12:1276. doi: 10.3390/jcm12041276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12041276</ArticleId><ArticleId IdType="pmc">PMC9963057</ArticleId><ArticleId IdType="pubmed">36835814</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannitsis E., Müller-Bardorff M., Kurowski V., Weidtmann B., Wiegand U., Kampmann M., Katus H.A. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation. 2000;102:211–217. doi: 10.1161/01.CIR.102.2.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.102.2.211</ArticleId><ArticleId IdType="pubmed">10889133</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorlu S.A. Value of computed tomography pulmonary angiography measurements in predicting 30-day mortality among patients with acute pulmonary embolism. Pol. J. Radiol. 2024;89:e225–e234. doi: 10.5114/pjr/186184.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pjr/186184</ArticleId><ArticleId IdType="pmc">PMC11210380</ArticleId><ArticleId IdType="pubmed">38938660</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasha S.M., Klok F.A., van der Bijl N., de Roos A., Kroft L.J., Huisman M.V. NT-pro-BNP levels in patients with acute pulmonary embolism are correlated to right but not left ventricular volume and function. Thromb. Haemost. 2012;108:367–372. doi: 10.1160/TH11-12-0901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH11-12-0901</ArticleId><ArticleId IdType="pubmed">22740123</ArticleId></ArticleIdList></Reference><Reference><Citation>Chornenki N.L.J., Poorzargar K., Shanjer M., Mbuagbaw L., Delluc A., Crowther M., Siegal D.M. Detection of right ventricular dysfunction in acute pulmonary embolism by computed tomography or echocardiography: A systematic review and meta-analysis. J. Thromb. Haemost. 2021;19:2504–2513. doi: 10.1111/jth.15453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15453</ArticleId><ArticleId IdType="pubmed">34245115</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>